73 related articles for article (PubMed ID: 15046942)
21. Stimulation of Rotator Cuff Repair by Sustained Release of Bone Morphogenetic Protein-7 Using a Gelatin Hydrogel Sheet.
Kabuto Y; Morihara T; Sukenari T; Kida Y; Oda R; Arai Y; Sawada K; Matsuda K; Kawata M; Tabata Y; Fujiwara H; Kubo T
Tissue Eng Part A; 2015 Jul; 21(13-14):2025-33. PubMed ID: 25819324
[TBL] [Abstract][Full Text] [Related]
22. Application of bladder acellular matrix in urinary bladder regeneration: the state of the art and future directions.
Pokrywczynska M; Gubanska I; Drewa G; Drewa T
Biomed Res Int; 2015; 2015():613439. PubMed ID: 25793199
[TBL] [Abstract][Full Text] [Related]
23. How does the pathophysiological context influence delivery of bone growth factors?
Yu X; Suárez-González D; Khalil AS; Murphy WL
Adv Drug Deliv Rev; 2015 Apr; 84():68-84. PubMed ID: 25453269
[TBL] [Abstract][Full Text] [Related]
24. Gelatin hydrogel impregnated with platelet-rich plasma releasate promotes angiogenesis and wound healing in murine model.
Notodihardjo PV; Morimoto N; Kakudo N; Matsui M; Sakamoto M; Liem PH; Suzuki K; Tabata Y; Kusumoto K
J Artif Organs; 2015 Mar; 18(1):64-71. PubMed ID: 25326193
[TBL] [Abstract][Full Text] [Related]
25. A perspective on the clinical translation of scaffolds for tissue engineering.
Webber MJ; Khan OF; Sydlik SA; Tang BC; Langer R
Ann Biomed Eng; 2015 Mar; 43(3):641-56. PubMed ID: 25201605
[TBL] [Abstract][Full Text] [Related]
26. A nanomedicine approach to effectively inhibit contracture during bladder acellular matrix allograft-induced bladder regeneration by sustained delivery of vascular endothelial growth factor.
Xiong Q; Lin H; Hua X; Liu L; Sun P; Zhao Z; Shen X; Cui D; Xu M; Chen F; Geng H
Tissue Eng Part A; 2015 Jan; 21(1-2):45-52. PubMed ID: 24947133
[TBL] [Abstract][Full Text] [Related]
27. Controlled release of granulocyte colony-stimulating factor enhances osteoconductive and biodegradable properties of Beta-tricalcium phosphate in a rat calvarial defect model.
Minagawa T; Tabata Y; Oyama A; Furukawa H; Yamao T; Yamamoto Y
Int J Biomater; 2014; 2014():134521. PubMed ID: 24829581
[TBL] [Abstract][Full Text] [Related]
28. Stem cells for urinary tract regeneration.
Bajek A; Drewa T; Joachimiak R; Marszałek A; Gagat M; Grzanka A
Cent European J Urol; 2012; 65(1):7-10. PubMed ID: 24578913
[TBL] [Abstract][Full Text] [Related]
29. Hepatocyte growth factor-loaded biomaterials for mesenchymal stem cell recruitment.
van de Kamp J; Jahnen-Dechent W; Rath B; Knuechel R; Neuss S
Stem Cells Int; 2013; 2013():892065. PubMed ID: 23861688
[TBL] [Abstract][Full Text] [Related]
30. Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain.
De Laporte L; Rice JJ; Tortelli F; Hubbell JA
PLoS One; 2013; 8(4):e62076. PubMed ID: 23637968
[TBL] [Abstract][Full Text] [Related]
31. Functionalization of biomaterial surfaces using artificial extracellular matrices.
Bierbaum S; Hintze V; Scharnweber D
Biomatter; 2012; 2(3):132-41. PubMed ID: 23507864
[TBL] [Abstract][Full Text] [Related]
32. Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure: new developments and challenges.
Finosh GT; Jayabalan M
Biomatter; 2012; 2(1):1-14. PubMed ID: 23507781
[TBL] [Abstract][Full Text] [Related]
33. Drug delivery systems: Advanced technologies potentially applicable in personalized treatments.
Coelho JF; Ferreira PC; Alves P; Cordeiro R; Fonseca AC; Góis JR; Gil MH
EPMA J; 2010 Mar; 1(1):164-209. PubMed ID: 23199049
[TBL] [Abstract][Full Text] [Related]
34. Tissue engineering for the oncologic urinary bladder.
Drewa T; Adamowicz J; Sharma A
Nat Rev Urol; 2012 Oct; 9(10):561-72. PubMed ID: 22907387
[TBL] [Abstract][Full Text] [Related]
35. Coadministration of platelet-derived growth factor-BB and vascular endothelial growth factor with bladder acellular matrix enhances smooth muscle regeneration and vascularization for bladder augmentation in a rabbit model.
Zhou L; Yang B; Sun C; Qiu X; Sun Z; Chen Y; Zhang Y; Dai Y
Tissue Eng Part A; 2013 Jan; 19(1-2):264-76. PubMed ID: 22894544
[TBL] [Abstract][Full Text] [Related]
36. Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery.
Demidova-Rice TN; Hamblin MR; Herman IM
Adv Skin Wound Care; 2012 Aug; 25(8):349-70. PubMed ID: 22820962
[TBL] [Abstract][Full Text] [Related]
37. Recommendations and considerations for the use of biologics in orthopedic surgery.
Zwingenberger S; Nich C; Valladares RD; Yao Z; Stiehler M; Goodman SB
BioDrugs; 2012 Aug; 26(4):245-56. PubMed ID: 22671767
[TBL] [Abstract][Full Text] [Related]
38. Angiogenesis.
Senger DR; Davis GE
Cold Spring Harb Perspect Biol; 2011 Aug; 3(8):a005090. PubMed ID: 21807843
[TBL] [Abstract][Full Text] [Related]
39. Dental pulp and dentin tissue engineering and regeneration: advancement and challenge.
Huang GT
Front Biosci (Elite Ed); 2011 Jan; 3(2):788-800. PubMed ID: 21196351
[TBL] [Abstract][Full Text] [Related]
40. Dual growth factor-releasing nanoparticle/hydrogel system for cartilage tissue engineering.
Lim SM; Oh SH; Lee HH; Yuk SH; Im GI; Lee JH
J Mater Sci Mater Med; 2010 Sep; 21(9):2593-600. PubMed ID: 20577785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
